Clinical Trials Logo

Asthma clinical trials

View clinical trials related to Asthma.

Filter by:

NCT ID: NCT00594750 Suspended - Asthma Clinical Trials

Mechanisms of Exacerbation of Asthma

MECA
Start date: May 2006
Phase:
Study type: Observational

The purpose of this study is to identify the causes of asthma that were not previously suspected, to better understand the effects of inhaled steroids on asthma and to identify new way to treat asthma.

NCT ID: NCT00592631 Terminated - Asthma Clinical Trials

Assessment Of The Effects Of Short and Long Term Use Of CPAP

Start date: February 2005
Phase: N/A
Study type: Interventional

We hypothesize that the nocturnal use of continuous positive airway pressure in adults and children with asthma will decrease airway reactivity.

NCT ID: NCT00590720 Terminated - Asthma Clinical Trials

A Phase 2A Study to Evaluate the Safety and Effect on Exercise Challenge Testing of MEDI-528 in Adults With Asthma

Start date: March 2008
Phase: Phase 2
Study type: Interventional

The main objective of this study is to evaluate the safety and tolerability of multiple fixed doses of MEDI-528 in adult patients with stable asthma and exercise-induced bronchoconstriction (EIB).

NCT ID: NCT00590304 Completed - Asthma Clinical Trials

Asthma in the Delta Region of Arkansas: Characterization of Disease and Impact of Environmental Factors

ADRA
Start date: October 2006
Phase: N/A
Study type: Observational

The purpose of the study is to evaluate asthma and examine the homes of children with asthma living in rural areas of the state. This study is being done to give investigators more information about the presence of allergens and endotoxin in the homes of children with asthma living in the delta region of Arkansas.

NCT ID: NCT00590005 Completed - Asthma Clinical Trials

Redox Determinants of Severe Asthma (a Substudy of the Severe Asthma Research Program)

SARP
Start date: January 2003
Phase: N/A
Study type: Observational

Hypotheses: 1) Airway pH regulation is abnormal in severe asthma; 2) In severe asthma, there is formation of cytotoxic nitrogen oxides and loss of beneficial nitrogen oxides in the airways

NCT ID: NCT00589719 Completed - Asthma Clinical Trials

Asthma in the Delta Region of Arkansas (ADRA): Prevalence and Morbidity

Start date: August 2005
Phase: N/A
Study type: Observational

The purpose of the study is to conduct a cross-sectional study to examine asthma prevalence and morbidity in a predominately minority, low-income population in rural Arkansas.

NCT ID: NCT00588406 Completed - Asthma Clinical Trials

Study of Budesonide as an Addition to Standard Therapy in Adult Asthmatics in the Emergency Room.

Start date: September 2007
Phase: Phase 3
Study type: Interventional

To determine whether adding nebulized inhaled steroids to the standard care of acutely ill ED patients with refractory acute asthma helps improve forced expiratory volume at one second (FEV1) and decrease the need for hospitalization.

NCT ID: NCT00587288 Completed - Asthma Clinical Trials

Efficacy and Safety Study of Reslizumab to Treat Poorly Controlled Asthma

Start date: November 2007
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine the effectiveness and safety of reslizumab (the drug under study) in the treatment of subjects with poorly controlled asthma.

NCT ID: NCT00585260 Completed - Asthma Clinical Trials

Mannitol Bronchoprovocation Challenge Ancillary Study/ACRN

Start date: December 2007
Phase: Early Phase 1
Study type: Interventional

This is an ancillary study conducted as part of the BASALT trial [NCT00495157]. The overall hypotheses are: 1) an indirect airway challenge procedure using mannitol can safely characterize asthma phenotypes, predict asthma control and exacerbations, predict responses to interventions, and perform more specifically than a direct methacholine challenge and; 2) PX27 pore function in whole blood correlates with measures of airway hyperresponsiveness induced by methacholine and/or mannitol challenges

NCT ID: NCT00585039 Completed - Asthma Clinical Trials

Albuterol Versus Xopenex in Treatment of Acute Asthma in the Emergency Department (ED)

Xopenex
Start date: September 2005
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine in a large, double-blind, randomized, prospective pediatric clinical trial whether the use of continuous levalbuterol (Xopenex) in addition to standard emergency department treatment for acute asthma exacerbations will improve the Forced Expiratory Volume in 1 sec (FEV 1) compared to the use of continuous racemic albuterol. The secondary objective is to correlate clinical (hospitalization rates and clinical asthma scores) with plasma levels of (S)-albuterol.